CDC guidance: can use topical agents as alternative first-line treatments.*
Barcoded/unit dose saves pharmacy time and labor.
Topical pain relievers start working on contact.
Treatment works locally with very little medicine traveling throughout the bloodstream.
Significant cost advantage vs. prescription pain relievers.
*CDC guidance for prescribing opiates for chronic pain
Salonpas Lidocaine 4% Patch
For patients suffering from back, muscle, or arthritis pain who are ineligible for reimbursement.
Salonpas Pain Relief Patch
The first OTC topical NSAID approved by the FDA. Clinically proven to treat mild and moderate musculoskeletal and arthritis pain.
Available from leading distributors
For sales support, please contact Northstar Sales Alliance (203) 222-8900.
Salonpas® is a trademark of Hisamitsu Pharmaceutical Co, Inc.
Follow RXinsider on Social Media
